CN Patent

CN120241601B — 盐酸麻黄碱注射液及其制剂工艺

Assigned to Chengdu Easton Biopharmaceuticals Co Ltd · Expires 2025-08-22 · 1y expired

What this patent protects

本发明属于药物制剂领域，具体涉及一种盐酸麻黄碱注射液及其制剂工艺。其盐酸麻黄碱注射液的处方由盐酸麻黄碱，氯化钠，抗氧剂，pH调节剂和注射用水组成，其中抗氧剂为抗坏血酸或硫代甘油中的一种，再加上经过优化后的制备工艺制备出的盐酸麻黄碱注射液，具有对人体的危害小、杂质含量低、质量稳定且安全的特点。

USPTO Abstract

本发明属于药物制剂领域，具体涉及一种盐酸麻黄碱注射液及其制剂工艺。其盐酸麻黄碱注射液的处方由盐酸麻黄碱，氯化钠，抗氧剂，pH调节剂和注射用水组成，其中抗氧剂为抗坏血酸或硫代甘油中的一种，再加上经过优化后的制备工艺制备出的盐酸麻黄碱注射液，具有对人体的危害小、杂质含量低、质量稳定且安全的特点。

Drugs covered by this patent

Patent Metadata

Patent number
CN120241601B
Jurisdiction
CN
Classification
—
Expires
2025-08-22
Drug substance claim
No
Drug product claim
No
Assignee
Chengdu Easton Biopharmaceuticals Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.